Jiny Drug Industry (600488.SH) subsidiary's Vitamin B injection has new specifications and has passed the consistency evaluation for generic drugs.

ZhonganAPP news, Jin Pharmaceutical (600488.SH) announced that its subsidiary Hubei Jin Pharmaceutical Co., Ltd. has received the "Drug Supplement Application Approval Notification" approved and issued by the National Medical Products Administration for Vitamin B injection, approving the addition of a 1ml:0.1g specification and passing the consistency evaluation of generic drug quality and efficacy (referred to as "consistency evaluation"). This drug is suitable for the prevention and treatment of Vitamin B deficiency.